EP Patent

EP2815749A1 — Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern

Assigned to IP Gesellschaft fuer Management mbH · Expires 2014-12-24 · 11y expired

What this patent protects

The invention relates to a packaging comprising one or more administration units comprising a solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione.

USPTO Abstract

The invention relates to a packaging comprising one or more administration units comprising a solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione.

Drugs covered by this patent

Patent Metadata

Patent number: EP2815749A1
Jurisdiction: EP
Classification: —
Expires: 2014-12-24
Drug substance claim: No
Drug product claim: No
Assignee: IP Gesellschaft fuer Management mbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.